| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.04. | Avalo Therapeutics Inc expected to post a loss of $1.18 a share - Earnings Preview | 14 | Reuters | ||
| 16.04. | Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades | 19 | Benzinga.com | ||
| 02.04. | Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why | 26 | Zacks | ||
| 02.04. | Avalo Therapeutics Appoints Biotech Leaders to Board of Directors | 8 | GlobeNewswire (USA) | ||
| 01.04. | Avalo Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 7 | Reuters | ||
| 01.04. | Avalo Therapeutics (AVTX) stock slips after earnings: buy the dip? | 8 | iNVEZZ.com | ||
| 01.04. | Avalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M | 13 | Seeking Alpha | ||
| 29.03. | Avalo Therapeutics: Avalo Reports 2023 Financial Results and Provides Business Updates | 98 | GlobeNewswire (Europe) | Acquired AVTX-009, Phase-2 ready anti-IL-1ß mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment... ► Artikel lesen | |
| 29.03. | Avalo Therapeutics, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
| 29.03. | Avalo Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 28.03. | Micro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin Disorder | 35 | Benzinga.com | ||
| 28.03. | Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today? | 23 | InvestorPlace | ||
| 27.03. | Avalo Therapeutics surges on buyout of privately held AlmataBio | 21 | Reuters | ||
| 27.03. | Avalo Therapeutics: Avalo Acquires Anti-IL-1ß mAb and Announces Private Placement Financing of up to $185 Million | 167 | GlobeNewswire (Europe) | Avalo acquires Phase 2-ready anti-IL-1ß mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis suppurativa expected in 2026Executed private... ► Artikel lesen | |
| 31.01. | Avalo Therapeutics, Inc. - 8-K, Current Report | 8 | SEC Filings | ||
| 28.12.23 | Avalo Therapeutics, Inc. - 8-K, Current Report | 17 | SEC Filings | ||
| 27.12.23 | Avalo Therapeutics announces a 1-for-240 reverse stock split | 15 | Seeking Alpha | ||
| 27.12.23 | Avalo Therapeutics Announces 1-for-240 Reverse Stock Split | 495 | GlobeNewswire (Europe) | WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 reverse stock split of the Company's common stock, par value $0.001... ► Artikel lesen | |
| 20.12.23 | Avalo Therapeutics, Inc. - 8-K, Current Report | 19 | SEC Filings | ||
| 07.12.23 | Avalo Therapeutics: Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split | 577 | GlobeNewswire (Europe) | Annual Meeting has been adjourned until December 20, 2023Most stockholders can vote via proxyvote.com or by calling 1-800-690-6903. If you have any questions about how to vote, please call 1-800-607-0088... ► Artikel lesen |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| PLUG POWER | 1.518 |
| MERCEDES-BENZ | 1.386 |
| EVOTEC | 1.267 |
| ALLIANZ | 937 |
| BAYER | 867 |
| TUI | 764 |
| NEL | 759 |
| SIEMENS ENERGY | 752 |
| BYD | 708 |
| PALANTIR TECHNOLOGIES | 663 |
| NVIDIA | 630 |
| DEUTSCHE BANK | 502 |
| RWE | 493 |
| DEUTSCHE LUFTHANSA | 450 |
| SUPER MICRO COMPUTER | 441 |
| RENK GROUP | 434 |
| VOLKSWAGEN | 426 |
| ARM | 408 |
| RHEINMETALL | 406 |
| TESLA | 405 |
| NORDEX | 395 |
| INFINEON | 382 |
| VARTA | 358 |
| FREENET | 355 |
| BASF | 354 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
